7,068 XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| James Brian Windsor | President and CEO | Purchase of securities on an exchange or from another person at price $ 2.24 per share. | 05 Dec 2024 | 239 | 239 (0%) | 0% | 2.2 | 535 | Common Stock |
| James Brian Windsor | President and CEO | Purchase of securities on an exchange or from another person at price $ 2.25 per share. | 05 Dec 2024 | 161 | 161 (0%) | 0% | 2.2 | 362 | Common Stock |
| Alan A. Musso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Joseph H. Von Rickenbach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Reinhard J. Ambros | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Manuel C. Alves-Aivado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| William Carl Fairey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| James Brian Windsor | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 517,500 | 517,500 | - | - | Stock Option (right to buy) | |
| Alan A. Musso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2024 | 2,725 | 2,725 | - | - | Stock Option (right to buy) | |
| Joseph H. Von Rickenbach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2024 | 2,725 | 2,725 | - | - | Stock Option (right to buy) | |
| Reinhard J. Ambros | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2024 | 2,725 | 2,725 | - | - | Stock Option (right to buy) | |
| Manuel C. Alves-Aivado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2024 | 2,725 | 2,725 | - | - | Stock Option (right to buy) | |
| William Carl Fairey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2024 | 2,725 | 2,725 | - | - | Stock Option (right to buy) | |
| James Brian Windsor | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2024 | 2,000 | 7,122 (0%) | 0% | - | Common Stock | |
| James Brian Windsor | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2024 | 2 | 0 | - | - | Series X Non-Voting Convertible Preferred | |
| J. Reinhard Ambros | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 2,725 | 2,725 | - | - | Stock Option (right to buy) | |
| H. Joseph Von Rickenbach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 2,725 | 2,725 | - | - | Stock Option (right to buy) | |
| Joseph H. Von Rickenbach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 2,725 | 2,725 | - | - | Stock Option (right to buy) | |
| Reinhard J. Ambros | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 2,725 | 2,725 | - | - | Stock Option (right to buy) | |
| Brian James Windsor | President and COO | Purchase of securities on an exchange or from another person at price $ 3.37 per share. | 15 Dec 2023 | 225 | 225 (0%) | 0% | 3.4 | 758 | Common Stock |
| Vojo Vukovic | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2022 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Manuel C. Alves Aivado | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2022 | 1,133,000 | 1,133,000 | - | - | Stock Option (right to buy) | |
| Allen Annis | SVP, Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2022 | 313,000 | 313,000 | - | - | Stock Option (right to buy) | |
| Richard J. Wanstall | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2022 | 393,000 | 393,000 | - | - | Stock Option (right to buy) | |
| William T. Mckee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 96,000 | 96,000 | - | - | Stock Option (right to buy) | |
| Vojo Vukovic | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Nolan Sigal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 96,000 | 96,000 | - | - | Stock Option (right to buy) | |
| Jeffrey Allen Bailey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 96,000 | 96,000 | - | - | Stock Option (right to buy) | |
| Jodie P. Morrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 96,000 | 96,000 | - | - | Stock Option (right to buy) | |
| Reinhard J. Ambros | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 96,000 | 96,000 | - | - | Stock Option (right to buy) | |
| Manuel C. Alves Aivado | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 2,440,000 | 2,440,000 | - | - | Stock Option (right to buy) | |
| Allen Annis | SVP, Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 474,000 | 474,000 | - | - | Stock Option (right to buy) | |
| Richard J. Wanstall | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 600,000 | 600,000 | - | - | Stock Option (right to buy) | |
| Von Rickenbach H. Joseph | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 96,000 | 96,000 | - | - | Stock Option (right to buy) | |
| Muneer A. Satter | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 1.10 per share. | 08 Jan 2021 | 9,000,000 | 16,609,449 (59%) | 32% | 1.1 | 9,900,000 | Common Stock |
| Richard J. Wanstall | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2020 | 91,000 | 91,000 | - | - | Stock Option (right to buy) | |
| William T. Mckee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Joseph H. Von Rickenbach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Nolan Sigal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Jeffrey Allen Bailey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Jodie P. Morrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Reinhard J. Ambros | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Jeffrey Allen Bailey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2020 | 54,500 | 54,500 | - | - | Stock Option (right to buy) | |
| Reinhard J. Ambros | Director | Purchase of securities on an exchange or from another person at price $ 1.22 per share. | 15 Jun 2020 | 5,800 | 5,800 (0%) | 0% | 1.2 | 7,076 | Common Stock |
| Joseph H. Von Rickenbach | Director | Purchase of securities on an exchange or from another person at price $ 1.10 per share. | 08 Jun 2020 | 227,272 | 445,460 (1%) | 0% | 1.1 | 249,999 | Common Stock |
| Muneer A. Satter | Other, See Remarks | Purchase of securities on an exchange or from another person at price $ 1.10 per share. | 08 Jun 2020 | 3,700,000 | 7,609,449 (27%) | 13% | 1.1 | 4,070,000 | Common Stock |
| Jeffrey Allen Bailey | None | Purchase of securities on an exchange or from another person at price $ 0.51 per share. | 14 Nov 2019 | 39,142 | 74,894 (0%) | 0% | 0.5 | 19,962 | Common Stock |
| Jeffrey Allen Bailey | None | Purchase of securities on an exchange or from another person at price $ 0.51 per share. | 14 Nov 2019 | 15,858 | 35,752 (0%) | 0% | 0.5 | 8,088 | Common Stock |
| Jeffrey Allen Bailey | None | Purchase of securities on an exchange or from another person at price $ 0.53 per share. | 12 Nov 2019 | 19,894 | 19,894 (0%) | 0% | 0.5 | 10,544 | Common Stock |
| Josef H. Von Rickenbach | None | Purchase of securities on an exchange or from another person at price $ 0.97 per share. | 12 Sep 2019 | 25,000 | 218,188 (0%) | 0% | 1.0 | 24,255 | Common Stock |
| Josef H. Von Rickenbach | None | Purchase of securities on an exchange or from another person at price $ 0.98 per share. | 12 Sep 2019 | 88,145 | 193,188 (0%) | 0% | 1.0 | 86,250 | Common Stock |
| Josef H. Von Rickenbach | None | Purchase of securities on an exchange or from another person at price $ 0.71 per share. | 04 Sep 2019 | 23,225 | 105,043 (0%) | 0% | 0.7 | 16,583 | Common Stock |
| Josef H. Von Rickenbach | None | Purchase of securities on an exchange or from another person at price $ 0.73 per share. | 30 Aug 2019 | 15,000 | 68,352 (0%) | 0% | 0.7 | 10,968 | Common Stock |
| Josef H. Von Rickenbach | None | Purchase of securities on an exchange or from another person at price $ 0.70 per share. | 30 Aug 2019 | 13,466 | 81,818 (0%) | 0% | 0.7 | 9,428 | Common Stock |
| Josef H. Von Rickenbach | None | Purchase of securities on an exchange or from another person at price $ 0.77 per share. | 29 Aug 2019 | 3,600 | 53,352 (0%) | 0% | 0.8 | 2,771 | Common Stock |
| Vojo Vukovic | SVP, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.59 per share. | 16 Aug 2019 | 75,000 | 75,000 (0%) | 0% | 0.6 | 44,453 | Common Stock |
| Kathryn Gregory | SVP, Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 13 Aug 2019 | 45,000 | 45,000 (0%) | 0% | 0.6 | 29,025 | Common Stock |
| John H. Mcarthur | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| William T. Mckee | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Josef H. Von Rickenbach | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Nolan Sigal | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Jeffrey Allen Bailey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Jodie P. Morrison | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Reinhard J. Ambros | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Vojo Vukovic | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2019 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Donald V. Dougherty | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2019 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Manuel C. Alves Aivado | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2019 | 500,000 | 500,000 | - | - | Stock Option (right to buy) | |
| Allen Annis | SVP, Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2019 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Kathryn Gregory | SVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2019 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Richard J. Wanstall | VP, Finance and Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2019 | 59,000 | 59,000 | - | - | Stock Option (right to buy) | |
| Nolan Sigal | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2019 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Kathryn Gregory | SVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2019 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Vojo Vukovic | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2018 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Manuel C. Alves Aivado | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2018 | 232,914 | 232,914 | - | - | Stock Option (right to buy) | |
| John P. Longenecker | President and CEO | Purchase of securities on an exchange or from another person at price $ 2.45 per share. | 10 Aug 2018 | 10,000 | 10,000 (0%) | 0% | 2.5 | 24,500 | Common Stock |
| John H. Mcarthur | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2018 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Jeffrey Allen Bailey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2018 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Jodie P. Morrison | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2018 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Reinhard J. Ambros | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2018 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Armen Shanafelt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2018 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Caleb Winder | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2018 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Donald V. Dougherty | SVP & Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 5.40 per share. | 08 Jun 2018 | 3,000 | 5,000 (0%) | 0% | 5.4 | 16,200 | Common Stock |
| Manuel C. Alves Aivado | See Remarks | Purchase of securities on an exchange or from another person at price $ 5.61 per share. | 06 Jun 2018 | 1,000 | 1,000 (0%) | 0% | 5.6 | 5,610 | Common Stock |
| Donald V. Dougherty | SVP & Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 5.24 per share. | 01 Jun 2018 | 2,000 | 2,000 (0%) | 0% | 5.2 | 10,480 | Common Stock |
| John P. Longenecker | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Jeffrey Allen Bailey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2018 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Reinhard J. Ambros | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2017 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| John H. Mcarthur | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2017 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Jodie P. Morrison | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2017 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Joseph A. Yanchik | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2017 | 157,449 | 157,449 | - | - | Stock Option (right to buy) | |
| Armen Shanafelt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2017 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Donald V. Dougherty | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2017 | 60,331 | 60,331 | - | - | Stock Option (right to buy) | |
| Manuel C. Alves Aivado | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2017 | 57,388 | 57,388 | - | - | Stock Option (right to buy) | |
| Kira A. Nelson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2017 | 36,844 | 36,844 | - | - | Stock Option (right to buy) | |
| Scott B. Kapnick | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2017 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Brian M. Gallagher | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2017 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Caleb Winder | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2017 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Muneer A. Satter | Ten Percent Owner | 05 Jul 2017 | 159,548 | 0 | - | - | Series E-3 Preferred Stock | ||
| Muneer A. Satter | Ten Percent Owner | 05 Jul 2017 | 847,721 | 0 | - | - | Series D Preferred Stock | ||
| Muneer A. Satter | Ten Percent Owner | 05 Jul 2017 | 183,944 | 0 | - | - | Series E-2 Preferred Stock | ||
| Muneer A. Satter | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 05 Jul 2017 | 33,333 | 178,106 (1%) | 0% | 15 | 499,995 | Common Stock |
| Muneer A. Satter | Ten Percent Owner | 05 Jul 2017 | 247,398 | 0 | - | - | Series F Preferred Stock | ||
| Muneer A. Satter | Ten Percent Owner | 05 Jul 2017 | 144,773 | 144,773 (1%) | 1% | 0 | Common Stock | ||
| Reinhard J. Ambros | None | 05 Jul 2017 | 4,238,607 | 0 | - | - | Series C-2 Preferred Stock | ||
| Reinhard J. Ambros | None | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 05 Jul 2017 | 266,667 | 2,544,182 (23%) | 2% | 15 | 4,000,005 | Common Stock |
| Reinhard J. Ambros | None | 05 Jul 2017 | 2,277,515 | 2,277,515 (20%) | 20% | 0 | Common Stock | ||
| Reinhard J. Ambros | None | 05 Jul 2017 | 3,705,882 | 0 | - | - | Series F Preferred Stock | ||
| Reinhard J. Ambros | None | 05 Jul 2017 | 2,293,829 | 0 | - | - | Series E-3 Preferred Stock | ||
| Reinhard J. Ambros | None | 05 Jul 2017 | 2,644,558 | 0 | - | - | Series E-2 Preferred Stock | ||
| Reinhard J. Ambros | None | 05 Jul 2017 | 6,781,770 | 0 | - | - | Series D Preferred Stock | ||
| Reinhard J. Ambros | None | 05 Jul 2017 | 2,967,025 | 0 | - | - | Series C Preferred Stock | ||
| Armen Shanafelt | None | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 05 Jul 2017 | 250,000 | 1,094,987 (9%) | 2% | 15 | 3,750,000 | Common Stock |
| Armen Shanafelt | None | 05 Jul 2017 | 1,907,373 | 0 | - | - | Series E-2 Preferred Stock | ||
| Armen Shanafelt | None | 05 Jul 2017 | 3,390,885 | 0 | - | - | Series D Preferred Stock | ||
| Armen Shanafelt | None | 05 Jul 2017 | 1,654,411 | 0 | - | - | Series E-3 Preferred Stock | ||
| Armen Shanafelt | None | 05 Jul 2017 | 1,443,972 | 0 | - | - | Series F Preferred Stock | ||
| Armen Shanafelt | None | 05 Jul 2017 | 844,987 | 844,987 (7%) | 7% | 0 | Common Stock | ||
| Scott B. Kapnick | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 05 Jul 2017 | 66,666 | 66,666 (0%) | 0% | 15 | 999,990 | Common Stock |
| Brian M. Gallagher | None | 05 Jul 2017 | 1,471,551 | 0 | - | - | Series E-2 Preferred Stock | ||
| Brian M. Gallagher | None | 05 Jul 2017 | 1,158,186 | 1,158,186 (10%) | 10% | 0 | Common Stock | ||
| Brian M. Gallagher | None | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 05 Jul 2017 | 273,333 | 1,431,519 (13%) | 2% | 15 | 4,099,995 | Common Stock |
| Brian M. Gallagher | None | 05 Jul 2017 | 1,979,188 | 0 | - | - | Series F Preferred Stock | ||
| Brian M. Gallagher | None | 05 Jul 2017 | 1,276,389 | 0 | - | - | Series E-3 Preferred Stock | ||
| Brian M. Gallagher | None | 05 Jul 2017 | 6,781,770 | 0 | - | - | Series D Preferred Stock | ||
| Donald V. Dougherty | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2017 | 140,887 | 140,887 | - | - | Stock Option (right to buy) |